[HTML][HTML] Hepatitis B virus molecular biology and pathogenesis

RJ Lamontagne, S Bagga, MJ Bouchard - Hepatoma research, 2016 - ncbi.nlm.nih.gov
As obligate intracellular parasites, viruses need a host cell to provide a milieu favorable to
viral replication. Consequently, viruses often adopt mechanisms to subvert host cellular …

Pathogenicity and virulence of Hepatitis B virus

YC Chuang, KN Tsai, JHJ Ou - Virulence, 2022 - Taylor & Francis
Hepatitis B virus (HBV) is a hepatotropic virus and an important human pathogen. There are
an estimated 296 million people in the world that are chronically infected by this virus, and …

Attacking hepatitis B virus cccDNA–The holy grail to hepatitis B cure

J Lucifora, U Protzer - Journal of hepatology, 2016 - Elsevier
HBV deposits a covalently closed circular DNA form, called cccDNA, in the nucleus of
infected cells. As the central transcription template, the cccDNA minichromosome is a key …

Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells

YZ Nie, YW Zheng, K Miyakawa, S Murata… - …, 2018 - thelancet.com
Therapies against hepatitis B virus (HBV) have improved in recent decades; however, the
development of individualized treatments has been limited by the lack of individualized …

Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options

FA Lempp, Y Ni, S Urban - Nature reviews Gastroenterology & …, 2016 - nature.com
Chronic hepatitis D is the most severe form of viral hepatitis, affecting∼ 20 million HBV-
infected people worldwide. The causative agent, hepatitis delta virus (HDV), is a unique …

HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models

J Torresi, BM Tran, D Christiansen, L Earnest-Silveira… - Bmc Cancer, 2019 - Springer
Abstract Background Hepatitis B virus (HBV) is the leading cause of liver cancer, but the
mechanisms by which HBV causes liver cancer are poorly understood and …

Cell and animal models for studying hepatitis B virus infection and drug development

J Hu, YY Lin, PJ Chen, K Watashi, T Wakita - Gastroenterology, 2019 - Elsevier
Many cell culture and animal models have been used to study hepatitis B virus (HBV)
replication and its effects in the liver; these have facilitated development of strategies to …

Experimental in vitro and in vivo models for the study of human hepatitis B virus infection

L Allweiss, M Dandri - Journal of hepatology, 2016 - Elsevier
Chronic infection with the hepatitis B virus (HBV) affects an estimate of 240 million people
worldwide despite the availability of a preventive vaccine. Medication to repress viral …

Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide

W He, B Ren, F Mao, Z Jing, Y Li, Y Liu, B Peng… - PLoS …, 2015 - journals.plos.org
Hepatitis D virus (HDV) is the smallest virus known to infect human. About 15 million people
worldwide are infected by HDV among those 240 million infected by its helper hepatitis B …

Chronic viral hepatitis and its association with liver cancer

T Tu, S Bühler, R Bartenschlager - Biological chemistry, 2017 - degruyter.com
Chronic infection with hepatitis viruses represents the major causative factor for end-stage
liver diseases, including liver cirrhosis and primary liver cancer (hepatocellular carcinoma …